Clinical Trial Update: Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

View source ↗

Summary

A clinical trial update indicating termination of the Cyberlink Control System study for amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease
• Neurodegenerative Disease

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Amyotrophic Lateral Sclerosis, Neurodegenerative Disease | Status: TERMINATED